Ledger.Open graph →
SEC Form D · filed September 26, 2013

PROVECTUS PHARMACEUTICALS INC

Offering
$16.0M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KNOXVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Brian A. Dahn · IRVINE, CAExecTimothy C. Scott · Knoxville, TNExec · DirectorRaffi Asadorian · EMERYVILLE, CADirectorPhilippe Boisseau · EMERYVILLE, CAExec · DirectorInderjit Singh · Grand Cayman, Cayman IslandsExecNancy K. Naeve · IRVINE, CADirectorElizabeth T. Gile · New York, NYExecDahn America360, LLC · IRVINE, CAExecFernando J. Reinach · EMERYVILLE, CADirectorJoel Cherry · EMERYVILLE, CADirectorGeoffrey J. Duyk · EMERYVILLE, CADirectorRaleigh A. Shoemaker · BOSTON, MAExec · DirectorDavid W. Menard · Wayne, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗